Stock Events

Stock Events

Lantern Pharma (LTRN) Q3 2025 Earnings

13AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.56

-0.51

-0.45

-0.4

Details

Expected EPS

-0.44

Actual EPS

-0.4

Surprise EPS

0.04

Surprise Percent

+9.09%

Description

Lantern Pharma (LTRN) has reported earnings of -0.4 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.